Open Access Open Access  Restricted Access Subscription Access

Medicinal significance and benefits of “Ashwagandha” (Withania somnifera) – A review

Dr. J.A.N. Sandamali, Dr. H.A.R.P. Perera

Abstract


 

Withania somnifera is an important staple plant in traditional Ayurvedic medicine. It has been traditionally used in Ayurveda for ages for its rasayana (Rejuvenation) properties. It is frequently mentioned in the religious, social, and medical treatises of India since the time of Vedic civilization. This research attempts to review medicinal value and health benefits according to Ayurvedic and modern pharmacological actions of Ashvagandha. Primary data was gathered from Ayurvedic textbooks and secondary data was collected from previous research articles following the PRISMA model. According to authentic books Ashvagandha, Karma (Therapiutic effects) including Vatakaphahara (balance nerve system and respiratory system) and immunity enhancing action.  Studies have revealed Withania somnifera contains active compounds including Withaferin-A, Withanone, Withastramonolide, 27-hydroxywithanone, Physagulin, Withanolide-A and etc. It may help to improve the strength of the body. According to this review Ashwagandha has hepatoprotective activity, cognition enhancing activity, cardioprotective activity, anti-ulcerogenic effect, antimicrobial activity and immunity enhancing action.


Full Text:

PDF

References


Bashir, A., Nabi, M2., Tabassum, N, Afzal, S and Ayoub, M. (2023). An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha). Frontiers in Pharmacology. 14.

Dar, N. J., and Muzamil, N. (2020). Neurodegenerative diseases and Withania somnifera (L.): An update. J. Ethnopharmacol. 256, 112769.

Ghias, U., Abdur, R., Sumaira, G., Muhammad, S., Salma, U., and Ajmal, K. (2013). Proximate chemical composition and biological profile of fatty acids of Withania somnifera L dunal. J. Med. Plants Res. 7 (27), 2034–2039.

Malik, T., Pandey, D. K., and Dogra, N. (2013). Ameliorative potential of aqueous root extract of Withania somnifera against paracetamol induced liver damage in mice. Pharmacologia 4 (2), 89–94.

Mohanty, I. R., Arya, D. S., and Gupta, S. K. (2008). Withania somnifera provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis. Clin Nutr 27 (4), 635–642.

Ng, Q. X., Loke, W., Foo, N. X., Tan, W. J., Chan, H. W., Lim, D. Y., et al. (2020). A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytotherapy Res. 34 (3), 583–590.

Niraj, S and Varsha, S. (2020). A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment of Covid-19. Plant Science Today 7(3), 417–423.

Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., et al. (2021). Withania somnifera (L.) dunal (ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomed. Pharmacother. 143, 112175.

Singh, N., Bhalla, M., Jager, P and Gilca, M. (2011). An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda. African Journal of Traditional Complementary and Alternative Medicine 8(5), 208–213.

Shalini.R., Eapen, J.K and Deepa, M. (2017). A LITERARY REVIEW ON ASHWAGANDHA (Withania somnifera (Linn) Dunal): AN AYURVEDIC APHRODISIAC DRUG. International Ayurvedic Medical Journal. 5(10), 3961-3969.

Vedi, M., Rasool, M., and Sabina, E. P. (2014). Amelioration of bromobenzene hepatotoxicity by Withania somnifera pretreatment: Role of mitochondrial oxidative stress. Toxicol. Rep. 1, 629–638.

Vedi, M., and Sabina, E. P. (2016). Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: Possible involvement of mitochondrial dysfunction and inflammation. 32 (5), 373–390.

Yadav, C. S., Kumar, V., Suke, S. G., Ahmed, R. S., Mediratta, P. K., and Banerjee, B. D. (2010). Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: Attenuation by Withania somnifera. Indian J. Biochem. Biophysics 47 (2), 117–120.

Zahiruddin, S., Basist, P., Parveen, A., Parveen, R., Khan, W., Gaurav, S., et al. (2020). Ashwagandha in brain disorders: A review of recent developments. J. Ethnopharmacol. 257, 112876.


Refbacks

  • There are currently no refbacks.